The Treatment of Renal Osteodystrophy
- 1 November 1966
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 65 (5) , 1133-1138
- https://doi.org/10.7326/0003-4819-65-5-1133
Abstract
The pathogenesis of azotemic osteodystrophy is still uncertain. The demonstration of impaired intestinal absorption of calcium (1, 2), the occurrence of rickets and osteomalacia (3, 4), and their cure by large amounts of vitamin D are all compatible with an acquired insensitivity to the biological effects of vitamin D (1-5). Hypocalcemia when present is associated with reduced osseous responsiveness to the calcemic action of exogenous parathyroid hormone (6), a functional abnormality also found in simple vitamin D deficiency (7). A degree of secondary hyperparathyroidism is to be expected with vitamin D deficiency, but the osseous manifestations of parathyroid activity areKeywords
This publication has 14 references indexed in Scilit:
- RENAL FUNCTION AND PHOSPHORUS EXCRETION AFTER HUMAN RENAL HOMOTRANSPLANTATIONThe Lancet, 1966
- Effects of parathyroidectomy and kidney transplantation on renal osteodystrophyThe American Journal of Surgery, 1965
- Concurrence of hyperplasia and neoplasia of the parathyroid glandsThe American Journal of Medicine, 1965
- Autonomous Secondary (Renal) Parathyroid HyperplasiaNew England Journal of Medicine, 1964
- Subtotal Parathyroidectomy in Azotemic Renal OsteodystrophyNew England Journal of Medicine, 1963
- METABOLIC STUDIES OF RENAL OSTEODYSTROPHYMedicine, 1962
- SUBTOTAL PARATHYROIDECTOMY FOR RENAL HYPERPARATHYROIDISMThe Lancet, 1961
- Genetics, hypersensitivity and the connective tissue diseasesThe American Journal of Medicine, 1961
- ELECTIVE SUBTOTAL PARATHYROIDECTOMY FOR RENAL HYPERPARATHYROIDISMThe Lancet, 1960
- AZOTAEMIC RENAL OSTEODYSTROPHYBritish Medical Bulletin, 1957